CDMO Cell Therapies

December 15, 2019

At the end of 2014, a new production area was initially established for an owned Cell Therapy Process.
The facilities were also designed to offer the development and GMP manufacturing of Autologous or Allogeneic cell therapy and tissue engineered products for third parties.

Last News

Upcoming events